Iylon Precision Oncology shared on Linkedin:
“Understanding How Skin Cancer Fights Back Against Immune Cells.
Immunotherapy helps the immune system fight melanoma, but not everyone responds the same way. Researchers studied how melanoma cells and immune cells interact by analyzing changes in proteins during an immune attack.
They discovered protein markers that may predict who will benefit from immunotherapy and identified weak points in melanoma that could be targeted with new treatments.
These findings could help advance precision oncology by improving biomarker discovery and enabling more personalized, effective immunotherapy for melanoma patients.
The following video further explains the role of Precision Oncology in Melanoma.
At Iylon Precision Oncology (www.iylon.com), we harness genetic insights to provide personalized, evidence-based recommendations, helping guide the right medicine, for the right patient, at the right dose, at the right time, and aimed at the right target.”
Other articles featuring Iylon Precision Oncology on OncoDaily.